Overview
Pierfrancesco Mastroeni practices practicing medicine in Siena, Italy.
Mastroeni is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Alkaptonuria, Ochronosis, and Primary Amyloidosis.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pierfrancesco Mastroeni
Is Pierfrancesco Mastroeni a top-rated expert for Alkaptonuria?
MediFind is an objective health platform that identifies experts based on real-world data. Pierfrancesco Mastroeni is classified as an Advanced expert for Alkaptonuria, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pierfrancesco Mastroeni participate in research or clinical trials?
Yes. Pierfrancesco Mastroeni has published 9 articles and abstracts on conditions like Alkaptonuria. You can view a list of Pierfrancesco Mastroeni's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AlkaptonuriaMastroeni isAdvanced. Learn about Alkaptonuria.
- OchronosisMastroeni isAdvanced. Learn about Ochronosis.
- Experienced
- Primary AmyloidosisMastroeni isExperienced. Learn about Primary Amyloidosis.